Vaccines containing antigenic components of the XBB variant have arrived in our province

Mondo Health Updated on 2024-01-28

Vaccines containing antigenic components of the XBB variant have arrived.

On December 7, the reporter learned from the Qinghai Provincial Center for Disease Control and Prevention that the vaccine containing the antigen component of the XBB variant has arrived in our province.

What are the precautions for vaccination with antigenic components of the XBB variant?Is it necessary to continue vaccination with vaccines containing antigenic components of the XBB variant?The Provincial Center for Disease Control and Prevention issued a reminder.

At present, the XBB variant of the new coronavirus is still the main epidemic strain in China, and the XBB variant has a strong immune escape ability, and the elderly and other key groups are more harmful after being infected with the XBB variant. This winter and next spring is a period of high incidence of respiratory tract-borne diseases, and it is still necessary for key groups to be vaccinated, and other groups should also make up for the gap in immunity level in a timely manner according to the vaccination plan. Elderly people aged 60 and above, people aged 18 to 59 with more serious underlying diseases, immunocompromised people, and people at high risk of infection;People who have completed basic immunization or have been infected with the new coronavirus are the target groups for this priority recommendation for vaccination with antigen components of XBB variants.

The interval between vaccinations containing antigenic components of the XBB variant is 3 to 6 months after the last dose (the most recent dose).6 months after the last infection;If both of the above situations occur, the most recent one shall prevail. The above people can receive 1 dose of vaccine containing the antigen component of the XBB variant.

However, those who are allergic to the active ingredient in the vaccine, any kind of inactive ingredient, substances used in the production process, or those who have developed allergies when previously vaccinated with the same type of vaccine;Those who have had severe allergic reactions in the past (such as acute allergic reactions, angioedema, dyspnea, etc.);Those with a history of seizures and other serious neurological diseases (such as transverse myelitis, Guillain-Barré syndrome, demyelinating diseases, etc.) in the past 6 months;Those who are having a fever, or suffering from an acute illness, or an acute attack of a chronic disease, or a severe chronic disease that is not controlled;It is not recommended for pregnant women.

For residents who need to be vaccinated, please consult the local CDC for details.

*: Xihai *** Author: Xu Bianyin.

Editor: Cao Maoshan Editor: Lu Dong Producer: Ma Zhenlong.

Related Pages